Canada Spends Logo

Explore our Budget 2026 analysis

Contribution: Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives

JRAS Medical Inc.

$146,063.00

Non-invasive Home Heart Failure Monitoring

FY 2025-26 · 2025-06-20

Summary
Heart failure is a devasting and chronic disease affecting an estimated 600,000 Canadians. It is characterized by episodes of severe shortness of breath and leg swelling resulting in frequent, prolonged hospital admissions and often high rate of hospital readmission. Congestive Heart Failure (CHF) symptoms are caused by pressure build-up within the heart. JVPLabs, in collaboration with the National Research Council, plans on developing a noninvasive home heart failure monitoring device that assesses key physiologic parameters important to the management of heart failure. The data collected by the JVPLabs device is transmitted to the heart failure clinical team enabling adjustment of medications that will keep the patient feeling well in the comfort of their own home.
Program
Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Location
St. John's|St. John's, Newfoundland and Labrador, Canada
Recipient Type
For-profit organization
Business Number
767414923
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions

As published

Agreement End Date
2026-08-31
Agreement Number
1029860
Agreement Start Date
2025-06-20
Agreement Title
Non-invasive Home Heart Failure Monitoring
Agreement Title (French)
Surveillance non invasive à domicile de l’insuffisance cardiaque
Agreement Type
Contribution
Agreement Value
$146,063.00
Amendment Number
0
Description
Heart failure is a devasting and chronic disease affecting an estimated 600,000 Canadians. It is characterized by episodes of severe shortness of breath and leg swelling resulting in frequent, prolonged hospital admissions and often high rate of hospital readmission. Congestive Heart Failure (CHF) symptoms are caused by pressure build-up within the heart. JVPLabs, in collaboration with the National Research Council, plans on developing a noninvasive home heart failure monitoring device that assesses key physiologic parameters important to the management of heart failure. The data collected by the JVPLabs device is transmitted to the heart failure clinical team enabling adjustment of medications that will keep the patient feeling well in the comfort of their own home.
Description (French)
L’insuffisance cardiaque est une maladie chronique dévastatrice qui affecte environ 600 000 Canadiens et Canadiennes. Elle se manifeste par des épisodes de grave essoufflement et d’enflure des jambes, entraînant des hospitalisations fréquentes et prolongées, ainsi qu’un taux élevé de réadmissions. Les symptômes de l’insuffisance cardiaque congestive (ICC) résultent d’une accumulation de pression dans le cœur. JVPLabs, en partenariat avec le Conseil national de recherches du Canada, prévoit de mettre au point un dispositif non invasif de surveillance à domicile de l’insuffisance cardiaque. Ce dispositif évaluera les principaux paramètres physiologiques essentiels à la gestion de l’insuffisance cardiaque. Les données recueillies par le dispositif de JVPLabs sont transmises à l’équipe clinique spécialisée en insuffisance cardiaque, ce qui permet d’ajuster les médicaments afin que le patient se sente bien dans le confort de son foyer.
Expected Results
In the short term, anticipated outcomes will be strengthened collaborations across industry, academia, and government to support research excellence. In the medium term, anticipated outcomes will be the development of new and potentially disruptive technologies with collaborators. In the long term, find collaborative solutions to public policy challenges and create stronger innovation systems.
Expected Results (French)
À court terme, les résultats prévus seront des collaborations renforcées entre l'industrie, le milieu universitaire et le gouvernement pour soutenir l'excellence en recherche. À moyen terme, les résultats attendus seront le développement de nouvelles technologies potentiellement perturbatrices avec des collaborateurs. À long terme, trouver des solutions collaboratives aux défis des politiques publiques et créer des systèmes d'innovation plus solides.
Federal Riding
St. John's East
Federal Riding (French)
St. John's-Est
Federal Riding Number
10006
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Program Name (French)
Programme de collaboration en science, en technologie et en innovation - Initiatives de collaboration en R-D
Program Purpose
Collaborate on multiparty research and development programs to catalyze transformative, high-risk, high-reward research with the potential for game-changing scientific discoveries and technological breakthroughs in priority areas.
Program Purpose (French)
Collaborer à des programmes multipartites de recherche-développement dans le but de profiter de la synergie entre la recherche transformatrice à haut risque et à haut rendement et le potentiel de découvertes scientifiques et de percées technologiques révolutionnaires dans des secteurs d’intervention prioritaires.
Recipient Business Number
767414923
Recipient City
St. John's|St. John's
Recipient Country
CA
Recipient Legal Name
JRAS Medical Inc.
Recipient Postal Code
A1C 1S9
Recipient Province or Territory
NL
Recipient Type
F
Reference Number
172-2025-2026-Q1-1029860
JRAS Medical Inc. - $146,063 Contribution (2025-26) | Canada Spends